SEC Form D · Amendment · filed August 9, 2024
Psy Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Paul F. Murphy · Boston, MADirectorAlan S. Cross · Boston, MADirectorWilliam F. Wagner · Boston, MAExecDaniel S. Weiss Pick · Boston, MADirectorJeff S. Troderman · Boston, MAExecDavid S. Barlow · Boston, MAExec · DirectorJerry F. Rosenbaum · Boston, MADirectorPhillip Mertz · Vancouver, British Columbia, CanadaExecGiada De Laurentiis · Los Angeles, CAExecAdrian De Valois-Franklin · Toronto, Ontario, CanadaDirectorCastle Ridge Ltd · Grand Cayman, Cayman IslandsDirectorPaul F. Murphy · Boston, MADirectorB.P. Martiuk · Grand Cayman, Cayman IslandsExec · DirectorChristopher G. Carter · DALLAS, TXDirectorStephen A. Foster · SAN FRANCISCO, CADirectorKarl O'Reilly · Grand Cayman, Cayman IslandsExec · DirectorMarc V. Teillon · SAN FRANCISCO, CADirectorKyle A. Kuczynski · Reno, NVDirectorWilliam P. Vernon · Reno, NVExecJason D. Molt · Reno, NVExecCurtis A. Lockshin, Ph.D · Marlborough, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗